Levetiracetam
NDC 69102-106, Levetiracetam, tablet, from OWP Pharmaceuticals, Inc..
- Product NDC
- 69102-106
- Status
- Listed
- Labeler
- OWP Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078858
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/69102-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LEVETIRACETAM750 mg/1
Pharmacologic classes
Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 69102-106-01 | 69102010601 | 120 TABLET in 1 BOTTLE (69102-106-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
RxNorm links no concept to this product's packages.
Related lookups
FDA label sections
GET /v1/drugs/labels/e662bf5b-c81c-4bcd-ba2e-552df95ca6f9
Use it
Look up 69102-106 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/69102-106 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 69102-106. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.